Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. | Int J Cancer | 2023 | 36250346 | PubTator, text mining | PubMed |
| Data-independent acquisition and quantification of extracellular matrix from human lung in chronic inflammation-associated carcinomas. | Proteomics | 2023 | 36228107 | PubTator, text mining | PubMed |
| Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer. | Cancer Med | 2023 | 36204983 | PubTator, text mining | PubMed |
| Remodelling landscape of tissue-engineered bladder with porcine small intestine submucosa using single-cell RNA sequencing. | Cell Prolif | 2023 | 36177893 | PubTator, text mining | PubMed |
Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods. | Comb Chem High Throughput Screen | 2023 | 35996248 | PubTator, text mining | PubMed |
| Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease. | Cardiovasc Res | 2023 | 35994249 | PubTator, text mining | PubMed |
| Dual-crosslinked regenerative hydrogel for sutureless long-term repair of corneal defect. | Bioact Mater | 2023 | 35800407 | PubTator, text mining | PubMed |
| Extracellular matrix in cancer progression and therapy. | Med Rev (2021) | 2022 | 37724245 | PubTator, text mining | PubMed |
| hsa-miR-508-5p as a New Potential Player in Intervertebral Disc Degeneration. | Int J Mol Cell Med | 2022 | 37091041 | PubTator, text mining | PubMed |
| Joint Secondary Transcriptomic Analysis of Non-Hodgkin's B-Cell Lymphomas Predicts Reliance on Pathways Associated with the Extracellular Matrix and Robust Diagnostic Biomarkers. | J Bioinform Syst Biol | 2022 | 36873459 | PubTator, text mining | PubMed |
| Developing a clinical grade human adipose decellularized biomaterial. | Biomater Biosyst | 2022 | 36824487 | PubTator, text mining | PubMed |
| Nutritional and lifestyle management of the aging journey: A narrative review. | Front Nutr | 2022 | 36761987 | PubTator, text mining | PubMed |
| Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma. | Front Oncol | 2022 | 36727080 | PubTator, text mining | PubMed |
| Single cell RNA-seq of human cornea organoids identifies cell fates of a developing immature cornea. | PNAS Nexus | 2022 | 36712326 | PubTator, text mining | PubMed |
| Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy. | Front Cardiovasc Med | 2022 | 36712235 | PubTator, text mining | PubMed |
| Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis. | Front Immunol | 2022 | 36700214 | PubTator, text mining | PubMed |
The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy. | Front Oncol | 2022 | 36686832 | PubTator, text mining | PubMed |
| Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer. | Front Oncol | 2022 | 36686780 | PubTator, text mining | PubMed |
| Superior survival for breast-conserving therapy over mastectomy in patients with breast cancer: A population-based SEER database analysis across 30 years. | Front Oncol | 2022 | 36686746 | PubTator, text mining | PubMed |
| Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36686485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=36